Preserve Access to Affordable Generics and Biosimilars Act : report together with additional views (to accompany H.R. 2375) (including cost estimate of the Congressional Budget Office).

Preserve Access to Affordable Generics and Biosimilars Act : report together with additional views (to accompany H.R. 2375) (including cost estimate of the Congressional Budget Office).

Saved in:

Bibliographic Details
Corporate Author:	United States. Congress. House. Committee on the Judiciary (Author)
Format:	Government Document Electronic eBook
Language:	English
Published:	[Washington, D.C.] : [U. S. Government Publishing Office], 2020-
Series:	Rept. / 116th Congress, 2d session, House of Representatives ; 116-693
Subjects:	Generic drugs > United States. Drugs > Prices > United States. Prescription pricing > Law and legislation > United States. Competition. Legislative materials.
Online Access:	CONNECT

Similar Items

Creating and Restoring Equal Access to Equivalent Samples Act of 2019 : report (to accompany H.R. 965) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Bringing Low-Cost Options and Competition while Keeping Incentives for New Generics Act of 2019 : report (to accompany H.R. 938) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining generic drug user fee amendments, focusing on accelerating patient access to generic drugs, January 28, 2016.
Published: (2018)

Orange Book Transparency Act of 2019 : report (to accompany H.R. 1503) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Generic drug user fee amendments : accelerating patient access to generic drugs : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session ... January 28, 2016.
Published: (2018)

Generic drugs : the pay-for-delay problem /
Published: (2011)

The effect of generic drug competition on generic drug prices during the Hatch-Waxman 180-day exclusivity period /
by: Olson, Luke M., et al.
Published: (2013)

Generic pharmaceuticals : marketplace access and consumer issues : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, April 23, 2002.
Published: (2004)

Sudden price spikes in off-patent drugs : perspectives from the front lines : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, first session, Washington, DC, December 9, 2015.
Published: (2022)

Generics and biosimilars initiative journal : GaBI journal.
Published: (2012)

Authorized generic pharmaceuticals : effects on innovation.
Published: (2013)

Expanding the use of generic drugs.
Published: (2010)

Authorized generic pharmaceuticals : effects on innovation [January 10, 2008] /
by: Thomas, John R., 1967-
Published: (2008)

Authorized generic pharmaceuticals : effects on innovation [August 8, 2006] /
by: Thomas, John R., 1967-
Published: (2006)

Examining issues related to competition in the pharmaceutical marketplace : a review of the FTC report, generic drug entry prior to patent expiration : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002.
Published: (2002)

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act : report (to accompany H.R 2374) (Including cost estimate of the Congressional Budget Office).
Published: (2020)

Generic drug user fee amendments (GDUFA) : background and reauthorization /
by: Bodie, Agata
Published: (2021)

Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, January 17, 2007.
Published: (2007)

Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.
Published: (2018)

Protecting Consumer Access to Generic Drugs Act of 2019 : report (to accompany H.R. 1499) (including cost estimate of the Congressional Budget Office).
Published: (2019)

Rules Committee print 116-14 : text of H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act : showing the text of H.R. 938, H.R. 1499, H.R. 965, H.R. 1385, H.R. 1386, H.R. 987, and H.R. 1010, as ordered reported by the Committee on Energy and Commerce, with modifications.
Published: (2019)

60 minutes.
Published: (2019)

Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017.
Published: (2018)

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Published: (2004)

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Published: (2004)

Affordable Prescriptions for Patients Through Promoting Competition Act : report (to accompany H.R 5133).
Published: (2020)

Generic drugs and GDUFA reauthorization : in brief.
Published: (2016)

Generic drugs and GDUFA reauthorization : in brief.
Published: (2017)

Closing the gaps in Hatch-Waxman : assuring greater access to affordable pharmaceuticals : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session on examining certain provisions of the 1984 Drug Price Competition and Patent Term Restoration Act, known as the Hatch-Waxman Act, assuring greater access to affordable pharmaceuticals, May 8, 2002.
Published: (2002)

Driving down the cost of drugs : battling big pharma in the statehouse /
by: Castellblanch, Ramón, 1948-
Published: (2012)

Price comparisons for pharmaceuticals : a review of U.S. and cross-national studies /
by: Danzon, Patricia Munch, 1946-
Published: (1999)

Journal of generic medicines.
Published: (2003)

Skyrocketing prescription drug costs : effects on senior citizens : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session, Lewiston, ME, April 15, 1992.
Published: (1993)

Generic drug laws : a decade of trial -- a prescription for progress /
Published: (1986)

Drug pricing : poor prescription for consumers and taxpayers? : hearing before the Committee on Governmental Affairs, United States Senate, One Hundred Third Congress, second session, July 27, 1994.
Published: (1995)

Generic : The Unbranding of Modern Medicine /
by: Greene, Jeremy A., 1974-
Published: (2014)

60 minutes.
Published: (2005)

Administered prices. hearings before the Subcommittee on Antitrust and Monopoly of the Committee on the Judiciary, United States Senate, Eighty-sixth Congress, second session pursuant to S. Res. 238.
Published: (1960)

Authorized generics : an interim report.
Published: (2009)

Prescription for good health : keeping pharmaceutical prices under control : a briefing /
Published: (1992)